MA39468B1 - Boissons énergisantes et autres adjuvants nutritionnels issus de spiritueux à base d'agave - Google Patents

Boissons énergisantes et autres adjuvants nutritionnels issus de spiritueux à base d'agave

Info

Publication number
MA39468B1
MA39468B1 MA39468A MA39468A MA39468B1 MA 39468 B1 MA39468 B1 MA 39468B1 MA 39468 A MA39468 A MA 39468A MA 39468 A MA39468 A MA 39468A MA 39468 B1 MA39468 B1 MA 39468B1
Authority
MA
Morocco
Prior art keywords
agave
energy drinks
nutritional additives
spirits
based spirits
Prior art date
Application number
MA39468A
Other languages
English (en)
Other versions
MA39468A (fr
Inventor
Robert W Brocia
Original Assignee
Roar Holding Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roar Holding Llc filed Critical Roar Holding Llc
Publication of MA39468A publication Critical patent/MA39468A/fr
Publication of MA39468B1 publication Critical patent/MA39468B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12H—PASTEURISATION, STERILISATION, PRESERVATION, PURIFICATION, CLARIFICATION OR AGEING OF ALCOHOLIC BEVERAGES; METHODS FOR ALTERING THE ALCOHOL CONTENT OF FERMENTED SOLUTIONS OR ALCOHOLIC BEVERAGES
    • C12H3/00—Methods for reducing the alcohol content of fermented solutions or alcoholic beverage to obtain low alcohol or non-alcoholic beverages
    • C12H3/04—Methods for reducing the alcohol content of fermented solutions or alcoholic beverage to obtain low alcohol or non-alcoholic beverages using semi-permeable membranes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/02—Food
    • G01N33/14—Beverages
    • G01N33/146—Beverages containing alcohol
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/904—Oxidoreductases (1.) acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/906—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)
    • G01N2333/90605—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4)
    • G01N2333/90633—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3) in general
    • G01N2333/90638—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3) in general with a definite EC number (1.4.3.-)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/10—Biofuels, e.g. bio-diesel

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)

Abstract

L'invention concerne des compositions contenant des inhibiteurs de la monoamine oxydase préparées par élimination de l'alcool présent dans des boissons issues de l'agave.
MA39468A 2014-09-16 2015-09-16 Boissons énergisantes et autres adjuvants nutritionnels issus de spiritueux à base d'agave MA39468B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462071179P 2014-09-16 2014-09-16
US201562231592P 2015-07-10 2015-07-10
PCT/US2015/050509 WO2016044473A1 (fr) 2014-09-16 2015-09-16 Boissons énergisantes et autres adjuvants nutritionnels issus de spiritueux à base d'agave

Publications (2)

Publication Number Publication Date
MA39468A MA39468A (fr) 2017-07-26
MA39468B1 true MA39468B1 (fr) 2020-09-30

Family

ID=55453705

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39468A MA39468B1 (fr) 2014-09-16 2015-09-16 Boissons énergisantes et autres adjuvants nutritionnels issus de spiritueux à base d'agave

Country Status (24)

Country Link
US (3) US10195163B2 (fr)
EP (1) EP3194557B1 (fr)
JP (3) JP6687626B2 (fr)
KR (1) KR20170074863A (fr)
CN (1) CN107250340B (fr)
AU (3) AU2015317751B2 (fr)
BR (1) BR112017005328B1 (fr)
CA (1) CA2961608C (fr)
CY (1) CY1123421T1 (fr)
DK (1) DK3194557T3 (fr)
ES (1) ES2818097T3 (fr)
HK (1) HK1244834A1 (fr)
HR (1) HRP20201466T1 (fr)
HU (1) HUE051469T2 (fr)
LT (1) LT3194557T (fr)
MA (1) MA39468B1 (fr)
MX (1) MX2017003554A (fr)
PL (1) PL3194557T3 (fr)
PT (1) PT3194557T (fr)
RS (1) RS60851B1 (fr)
RU (1) RU2742610C2 (fr)
SI (1) SI3194557T1 (fr)
WO (1) WO2016044473A1 (fr)
ZA (1) ZA201702165B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107250340B (zh) * 2014-09-16 2021-05-07 罗伯特·布洛西亚 源自基于龙舌兰的烈酒的能量饮品和其他营养辅助物
WO2018187628A1 (fr) 2017-04-05 2018-10-11 Roar Holding, Llc Procédé perfectionné pour l'isolement d'inhibiteurs de la monoamine-oxydase (mao) à partir de tequila ou autres produits de fermentation d'agave distillés
CN109370848B (zh) * 2018-11-05 2022-03-15 福建农林大学 一种红曲龙舌兰酒的加工方法
CA3121090A1 (fr) 2018-11-26 2020-06-04 Roar Holding Llc Procedes d'amelioration de la qualite d'une boisson
US11839622B1 (en) 2020-01-15 2023-12-12 Randall Lewarchik Consumable nutraceutical composition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6091997A (ja) * 1983-10-22 1985-05-23 Wako Pure Chem Ind Ltd モノアミンオキシダ−ゼ活性の測定方法
US4612196A (en) * 1984-08-23 1986-09-16 Miller Brewing Company Preparation of low alcohol beverages by reverse osmosis
US5262162A (en) 1991-09-06 1993-11-16 Merz & Co. Gmbh & Co. Cerebral-activating extract
US6506430B1 (en) * 1995-07-21 2003-01-14 Brown-Forman Corporation Oak aged alcoholic beverage extract and accelerated whisky maturation method
AU770309B2 (en) * 1998-06-05 2004-02-19 Regent Court Technologies Monoamine oxidase (MAO) inhibitors and uses thereof
JP4319735B2 (ja) * 1999-03-12 2009-08-26 丸善製薬株式会社 モノアミンオキシダーゼ阻害剤および飲食物
BRPI0801239A2 (pt) * 2008-04-01 2009-11-17 Ache Lab Farmaceuticos Sa uso de um ou mais benzopiranonas, composição farmacêutica e método de prevenção ou tratamento de doenças, disfunções e distúrbios associados a monoamino oxidase
US20100178411A1 (en) * 2009-01-13 2010-07-15 Alma Imports, Inc. Agave-plant-based composition of matter and methods of use
US8658236B2 (en) * 2009-08-21 2014-02-25 Deuteria Beverages, Llc Alcoholic compositions having a lowered risk of acetaldehydemia
CN103119172B (zh) 2010-06-18 2016-05-11 布特马斯先进生物燃料有限责任公司 在提取发酵中用于醇移除的来源于油的提取溶剂
CA2783847C (fr) * 2012-07-24 2014-09-30 Luc Hobson Boisson ou produit alimentaire a teneur reduite en calorie et procede et appareil pour fabriquer celui-ci
US8609162B2 (en) * 2012-10-04 2013-12-17 Invivo Beverages Llc Integrated neuromodulation system for mood enhancement of a living human subject
CN107250340B (zh) * 2014-09-16 2021-05-07 罗伯特·布洛西亚 源自基于龙舌兰的烈酒的能量饮品和其他营养辅助物

Also Published As

Publication number Publication date
PL3194557T3 (pl) 2021-04-06
US10195163B2 (en) 2019-02-05
RS60851B1 (sr) 2020-10-30
SI3194557T1 (sl) 2020-11-30
PT3194557T (pt) 2020-09-21
LT3194557T (lt) 2020-11-25
AU2021232783B2 (en) 2024-05-09
MA39468A (fr) 2017-07-26
US11160774B2 (en) 2021-11-02
DK3194557T3 (da) 2020-09-21
RU2017112984A3 (fr) 2019-09-16
AU2020200964A1 (en) 2020-02-27
AU2015317751B2 (en) 2019-11-14
RU2017112984A (ru) 2018-10-17
US20220047531A1 (en) 2022-02-17
RU2742610C2 (ru) 2021-02-09
BR112017005328A2 (pt) 2017-12-12
JP2020110180A (ja) 2020-07-27
BR112017005328B1 (pt) 2021-11-16
WO2016044473A1 (fr) 2016-03-24
MX2017003554A (es) 2017-06-30
AU2021232783A1 (en) 2021-10-14
AU2015317751A1 (en) 2017-05-04
CA2961608A1 (fr) 2016-03-24
CN107250340A (zh) 2017-10-13
KR20170074863A (ko) 2017-06-30
JP2023052345A (ja) 2023-04-11
CN107250340B (zh) 2021-05-07
CY1123421T1 (el) 2021-12-31
HUE051469T2 (hu) 2021-03-01
JP6687626B2 (ja) 2020-04-22
EP3194557B1 (fr) 2020-07-01
NZ730510A (en) 2024-03-22
ZA201702165B (en) 2018-04-25
ES2818097T3 (es) 2021-04-09
EP3194557A1 (fr) 2017-07-26
CA2961608C (fr) 2023-02-07
US20160074343A1 (en) 2016-03-17
HK1244834A1 (zh) 2018-08-17
JP2017529102A (ja) 2017-10-05
EP3194557A4 (fr) 2018-06-06
US20190231717A1 (en) 2019-08-01
JP7212001B2 (ja) 2023-01-24
HRP20201466T1 (hr) 2021-03-05

Similar Documents

Publication Publication Date Title
MX2019012431A (es) Inhibidores del receptor de hidrocarburos de arilo (ahr) de indol y usos de los mismos.
EA201691794A1 (ru) Конденсированные [1,4]диазепиновые соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa)
MX2016015565A (es) Ciertos inhibidores de la proteina quinasa.
EA201892147A1 (ru) Бициклические соединения
EA201691916A1 (ru) Биарильные ингибиторы киназы
MA39468B1 (fr) Boissons énergisantes et autres adjuvants nutritionnels issus de spiritueux à base d'agave
EA201490826A1 (ru) Ингибиторы асс и их применения
PH12018500408A1 (en) Bicyclic compounds as atx inhibitors
EA201691799A1 (ru) Бициклические соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa)
AU2015208932A8 (en) (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase I inhibitors
SG10201809518QA (en) Processes of preparing a jak1 inhibitor and new forms thereto
AU2017317563A8 (en) Detergent compositions comprising xanthan lyase variants I
MX2021003792A (es) Inhibidores de benzoquinolina del transportador vesicular de monoaminas 2.
EA201892123A1 (ru) 6-гидрокси-4-оксо-1,4-дигидропиримидин-5-карбоксамиды в качестве агонистов apj
EA201690022A1 (ru) Ингибиторы коррозии на основе органических дисульфидов
TN2014000016A1 (en) 4 - piperidinyl compounds for use as tankyrase inhibitors
HRP20090213A2 (en) Process and intermediates for preparing integrase inhibitors
EA201391274A1 (ru) Аминохинолины в качестве ингибиторов киназ
WO2018136437A3 (fr) Nouveaux composés utiles en tant qu'inhibteurs de l'indoléamine 2,3-dioxygénase et/ou du tryptophane dioxygénase
EA201490846A1 (ru) Новые производные арилхинолина
EA201491647A1 (ru) Основанные на арилэфирах ингибиторы киназ
EA201691397A1 (ru) Хинолиновые ингибиторы киназы
MX2018006680A (es) Composiciones de barreras de luz y artículos que las comprenden.
MX2018013164A (es) Compuestos novedosos de imidazopiridina sustituida como inhibidores de indolamina-2,3-dioxigenasa y/o triptofano-2,3-dioxigenasa.
EA201590268A1 (ru) Ариллактамные ингибиторы киназы